TFRC and cancer: In survival analyses, lower TfR1 expression in benign kidney tissue of ccRCC patients was associated with a significantly shorter time to metastasis (p<0.001), cancer-specific death (p<0.001) and death due to any cause (p<0.001) (Figure 6A, Table 5).